Tags: axa health | wegovy | weight loss | treatment

British Insurer Won't Pay for Wegovy Weight-Loss Treatment

a box labeled wegovy
The preparation Wegovy from Novo Nordisk is used to treat type 2 diabetes and as a slimming agent. (AP)
 

Monday, 04 September 2023 09:19 AM EDT

British private insurer AXA Health has said it will not pay for treatment with Novo Nordisk's weight-loss drug Wegovy, which launched in the U.K. on Monday.

AXA Health told Reuters in a statement: "As it stands, AXA Health would not cover the use of Wegovy as this would be prescribed as an outpatient drug for a chronic condition."

It declined to say how many people in the U.K. it insures, citing commercial sensitivity. 

© 2025 Thomson/Reuters. All rights reserved.


Newsfront
British private insurer AXA Health has said it will not pay for treatment with Novo Nordisk's weight-loss drug Wegovy, which launched in the U.K. on Monday. AXA Health told Reuters in a statement: "As it stands, AXA Health would not cover the use of Wegovy as this would be...
axa health, wegovy, weight loss, treatment
73
2023-19-04
Monday, 04 September 2023 09:19 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved